Pharmacology of Liposomal Amphotericin B: An Introduction to Preclinical and Clinical Advances for Treatment of Life-threatening Invasive Fungal Infections-Reference-Cited by-同舟云学术

Pharmacology of Liposomal Amphotericin B: An Introduction to Preclinical and Clinical Advances for Treatment of Life-threatening Invasive Fungal Infections

Published:2019-05-02 Issue:Supplement_4 Volume:68 Page:S241-S243
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Walsh Thomas J¹,Lewis Russell E²,Adler-Moore Jill³

Affiliation:

1. Departments of Medicine, Pediatrics, and Microbiology & Immunology, Weill Cornell Medicine of Cornell University, New York, New York

2. Unit of Infectious Diseases, Policlinico Sant’Orsola-Malpighi, Department of Medical Sciences and Surgery, University of Bologna, Italy

3. Department of Biological Sciences, California State Polytechnic University, Pomona

Funder

Gilead Sciences

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/68/Supplement_4/S241/28549169/ciz091.pdf

Reference46 articles.

1. Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use;Aversa;J Chemother,2017

2. Liposomal formulations in clinical use: an updated review;Bulbake;Pharmaceutics,2017

3. Liposomal amphotericin B (AmBisome®): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions;Stone;Drugs,2016

4. Preclinical safety, tolerability, pharmacokinetics, pharmacodynamics, and antifungal activity of liposomal amphotericin B;Adler Moore;Clin Infect Dis,2019

5. Clinical safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of liposomal amphotericin B;Groll;Clin Infect Dis,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming the Challenges in Topical Delivery of Antifungal Agents for Skin Fungal Infections;Current Drug Therapy;2024-08-02

2. Pharmacovigilance study of amphotericin B for mucormycosis in post-COVID and non-COVID patients at a tertiary care hospital in Eastern India;Indian Journal of Pharmacology;2022-11

3. Mucormycosis: The hidden and forgotten disease;Journal of Applied Microbiology;2022-06-01

4. Invasive Aspergillus outbreak in inhalation injury: a case presentation and literature review;BMC Infectious Diseases;2022-04-18

5. Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B;Medical Mycology;2020-01-21